Brenda Furlow

2018

In 2018, Brenda Furlow earned a total compensation of $1.2M as Senior Vice President General Counsel at Bio-Techne, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$250,132
Option Awards$431,239
Salary$385,000
Stock Awards$143,731
Other$8,100
Total$1,218,802

Furlow received $431.2K in option awards, accounting for 35% of the total pay in 2018.

Furlow also received $250.1K in non-equity incentive plan, $385K in salary, $143.7K in stock awards and $8.1K in other compensation.

Rankings

In 2018, Brenda Furlow's compensation ranked 8,210th out of 14,244 executives tracked by ExecPay. In other words, Furlow earned more than 42.4% of executives.

ClassificationRankingPercentile
All
8,210
out of 14,244
42nd
Division
Manufacturing
3,242
out of 5,758
44th
Major group
Chemicals And Allied Products
1,216
out of 2,119
43rd
Industry group
Drugs
1,016
out of 1,808
44th
Industry
Biological Products, Except Diagnostic Substances
193
out of 339
43rd
Source: SEC filing on September 9, 2019.

Furlow's colleagues

We found four more compensation records of executives who worked with Brenda Furlow at Bio-Techne in 2018.

2018

Charles Kummeth

Bio-Techne

Chief Executive Officer

2018

James Hippel

Bio-Techne

Chief Financial Officer

2018

David Eansor

Bio-Techne

Senior Vice President Biotechnology

2018

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

News

You may also like